Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05817903
Title Phase II Study of Axitinib Intensification Plus Nivolumab Compared to Nivolumab Alone After Induction With Nivolumab Plus Ipilimumab in mRCC Patients Without Previous CR (AxIn)
Acronym AxIn
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Consorzio Oncotech
Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.